Skip to main content

Dermatology · UK

psoriasis treatment - a consultant dermatologist and the full ladder - topicals to biologics.

A structured private psoriasis pathway - consultant dermatologist review, disease severity scoring, phototherapy, apremilast, methotrexate, ciclosporin and modern biologics through the full BAD-guided ladder. Skin, joints, mental health and cardiovascular risk all considered.

See indicative pricing
A radiographer guides a patient onto the bed of an advanced 3 Tesla MRI scanner in a London imaging suite

Indicative pricing

What private psoriasis treatment costs in the UK.

Indicative ranges across our consultant dermatology partners. Firm quotes with drug, phototherapy and monitoring costs itemised.

In short

from £280 per visit, biologic-based years typically £8,000–£16,000.

OptionIndicative range
Consultant dermatology consultation£280–£450
Topical therapy programme (year 1)£400–£1,200
Narrow-band UVB phototherapy (course)£1,200–£3,500
Methotrexate or ciclosporin (year 1)£900–£2,400
Apremilast (year 1)£3,500–£6,500
Biologic therapy (year 1, self-pay)£8,000–£16,000
PsA rheumatology referral£350–£650

Prices vary by clinic, by consultant seniority and by whether combined visits or extra work-up is needed.

The problem

Psoriasis is not just a skin problem.

Up to 30% of patients develop psoriatic arthritis, cardiovascular risk is raised, and the mental-health burden is significant. Good care addresses all four.

  • Screen for psoriatic arthritis every visit

    A PEST questionnaire, a joint exam, and - where positive - a rheumatology referral. Early intervention preserves joints.

  • Cardiovascular risk deserves the same attention as skin

    Blood pressure, lipids, HbA1c, weight and lifestyle. Psoriasis raises cardiovascular risk independent of severity.

  • Mental health matters

    Depression, anxiety and impact on relationships and work are common. Screen for them; treat them; do not leave them for someone else.

When it helps

When treatment escalation is the right call.

The patterns of psoriasis where escalation is warranted - plus the red flag that means A&E rather than an outpatient booking.

  • Plaque psoriasis (chronic plaque)

    The commonest form - thick red plaques with silvery scale on scalp, elbows, knees and lower back.

  • Scalp psoriasis

    Thick scale on the scalp, often extending to hairline and behind the ears - undertreated with generic shampoos.

  • Nail psoriasis

    Pitting, onycholysis and oil-drop signs - often signal higher risk of psoriatic arthritis and benefit from systemic treatment.

  • Guttate psoriasis

    Small drop-like lesions after a streptococcal throat infection - often responds well to phototherapy.

  • Inverse (flexural) psoriasis

    Smooth red plaques in armpits, groin and under breasts - needs mild topicals rather than potent steroids.

  • Palmoplantar psoriasis

    Thick scale, cracks and pustules on palms and soles - disabling for work, often needs systemic treatment.

  • Psoriatic arthritis

    Joint pain, stiffness and swelling - screen every psoriasis patient every visit and escalate to rheumatology promptly.

  • Red flag: generalised pustular or erythrodermic psoriasis

    Widespread pustules with fever, or the whole skin red and shedding, is a dermatological emergency - A&E, not an outpatient booking.

Treatment options

A therapy ladder, not a single pill.

Every rung of the modern psoriasis treatment ladder, and how the choice is made per patient.

  • Topicals - potent corticosteroids + vitamin D analogues

    The first-line combination for mild-to-moderate plaque disease. Effective, cheap, needs proper counselling and rotation.

  • Tazarotene and coal tar

    Older topicals still useful in selected patients; tar has a role in scalp and thick plaque disease.

  • Narrow-band UVB phototherapy

    Two to three sessions a week for 8–12 weeks - clears many patients with moderate disease and buys a drug-free interval.

  • Methotrexate

    Weekly oral or subcutaneous - the traditional systemic. Cheap, well understood, needs monthly blood monitoring.

  • Ciclosporin

    Fast-acting oral systemic - used to break severe flares. Blood pressure and renal monitoring; usually a short course.

  • Apremilast (PDE4 inhibitor)

    Oral, no bloods needed. Modest efficacy - a good bridge for patients not ready for injectables.

  • Biologics - TNF, IL-17, IL-23 inhibitors

    Highly effective for moderate-to-severe disease and psoriatic arthritis. Self-injected. Screening and long-term monitoring needed.

  • JAK inhibitors and newer oral options

    Deucravacitinib and others - a growing oral option for moderate-to-severe disease; specialist prescribing.

Safety and recovery

undefined

undefined

  • Steroid rotation prevents skin atrophy

    Potent topicals should not run continuously on the same area for months. Rotation and steroid-sparing agents are standard.

  • Phototherapy carries a small skin-cancer signal

    Cumulative UVB exposure is tracked over a lifetime. Skin surveillance and dose ceilings are standard.

  • Methotrexate needs monthly bloods

    Liver, kidney and marrow function; folic acid daily except on the dose day; alcohol restraint; and pregnancy avoidance for both partners.

  • Ciclosporin is short-course by design

    Blood pressure and renal function monitored - usually 3–6 months at a time.

  • Biologics need pre-treatment screening

    TB (IGRA), hepatitis B and C, HIV, immunisation review and - for some agents - pregnancy planning. Long-term infection surveillance continues.

  • Vaccination planning is essential

    Live vaccines are avoided on many systemic and biologic therapies. Annual flu and pneumococcal are standard.

  • Cardiovascular and metabolic care

    Blood pressure, lipids, HbA1c and weight annually. Psoriasis raises cardiovascular risk - treat it explicitly.

  • Mental health is part of psoriasis care

    Depression, anxiety and impact on relationships and work - asked at every visit, treated, not deferred.

  • Flare triggers

    Streptococcal infection, alcohol, smoking, stress and some medications (beta-blockers, lithium, hydroxychloroquine, sudden steroid withdrawal) - we identify and address them.

Reading your dermatology record

Your psoriasis record in four parts. Read the last one first.

Severity scoring, treatment record, monitoring results and forward plan - the parts a good dermatology clinic should send after every visit.

A UK consultant reviewing a patient record

A quiet reminder

Skin, joints, heart and mind - a psoriasis review that misses any of these is incomplete. We insist on all four.

Ask your care team to explain anything that is unclear.

  1. 01Severity

    PASI, BSA and DLQI

    Objective disease measures - Psoriasis Area and Severity Index, Body Surface Area, Dermatology Life Quality Index - recorded at every visit.

  2. 02Treatment

    Current therapy and response

    What you are on, how you are taking it and how you have responded - PASI 75, 90, 100 targets discussed against your baseline.

  3. 03Monitoring

    Blood work and comorbidity checks

    Bloods, blood pressure, joint screen (PEST), cardiovascular risk and mental health screen - all recorded and actioned.

  4. 04Impression

    Next step and safety net

    Read this first: whether to continue, escalate or swap; when to review; and what to do if you flare or develop joint symptoms.

Recognised by major UK insurers

BupaAXA HealthVitalityAvivaWPACignaHealixBupaAXA HealthVitalityAvivaWPACignaHealixBupaAXA HealthVitalityAvivaWPACignaHealix

Consultations and standard systemics are usually covered when medically indicated.

Frequently asked

Everything we get asked about psoriasis treatment.

Quick answers on cost, safety, recovery and how we compare with the NHS pathway.

  • What causes psoriasis?

    Psoriasis is a chronic immune-mediated skin disease with strong genetic and environmental drivers. Streptococcal infection, stress, alcohol, smoking and some medications can trigger flares. It is not infectious and not caused by hygiene.

  • What is the best treatment for psoriasis?

    There is no single best treatment - the right choice depends on severity, distribution, comorbidities and your life. Mild disease usually starts with topicals; moderate disease with phototherapy or apremilast; moderate-to-severe with methotrexate, ciclosporin or a biologic. Biologics are now first-line for many patients with moderate-to-severe disease or psoriatic arthritis.

  • Are biologics safe long-term?

    Modern biologics - anti-TNF, anti-IL-17, anti-IL-23 - have a good long-term safety profile with proper screening and monitoring. TB, hepatitis, HIV and vaccination review before starting; annual monitoring after. The commonest issues are injection-site reactions and infections; specific agents have specific cautions.

  • What is psoriatic arthritis and how would I know?

    Up to 30% of psoriasis patients develop inflammatory arthritis, sometimes years before the skin. Symptoms include morning joint stiffness, painful swollen fingers or toes, low back pain that improves with movement, and heel or Achilles pain. Any of these means a rheumatology review.

  • Is phototherapy safe?

    Narrow-band UVB is safe and effective for many moderate psoriasis patients - a 20–36 session course. Skin cancer risk is small and dose-tracked over a lifetime. It is often the right rung of the ladder for patients who prefer to avoid systemic therapy.

  • How much does private psoriasis treatment cost in the UK?

    Consultations from £280. Topical programmes £400–£1,200 a year. Phototherapy courses £1,200–£3,500. Methotrexate or ciclosporin £900–£2,400 in year one. Apremilast £3,500–£6,500. Biologics £8,000–£16,000 a year at private prices.

  • Should I use the NHS instead?

    For biologic-eligible patients, the NHS is often the faster and more affordable route - dedicated biologics pathways exist. Private care makes sense for speed of specialist review, flexibility of appointments and choice of consultant. We say so honestly at the first call.

  • What lifestyle changes actually help?

    Stop smoking, moderate alcohol, treat any streptococcal throat infection promptly, and address weight, blood pressure and lipids. There is no evidence for elimination diets. Emollients daily, whether or not you are flaring, is a low-effort win.

Related treatments

Looking for something else?